Bulk Manufacturer of Controlled Substances Application: Purisys, LLC, 48563 [2020-17438]

Download as PDF 48563 Federal Register / Vol. 85, No. 155 / Tuesday, August 11, 2020 / Notices Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on June 24, 2020, Cedarburg Pharmaceuticals, 870 Badger Circle, Grafton, Wisconsin 53024–0000, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: ADDRESSES: Controlled substance Tetrahydrocannabinols .. Methylphenidate ............ Nabilone ........................ 4-Anilino-N-phenethyl-4piperidine (ANPP). Fentanyl ......................... Drug code Schedule 7370 1724 7379 8333 I II II II 9801 II 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on July 10, 2020, Epic Pharma, LLC, 227–15 North Conduit Avenue, Laurelton, New York 11413 applied to be registered as an importer of the following basic class(es) of a controlled substance: Controlled substance The company plans to manufacture bulk active pharmaceutical ingredients (API) for distribution to its customers. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to bulk manufacture as synthetic. No other activity for this drug code is authorized for this registration. Methadone .................... Drug code 9250 Schedule The company plans to import the listed controlled substance for research and analytical purposes. William T. McDermott, Assistant Administrator. DEPARTMENT OF JUSTICE [Docket No. DEA–701] Bulk Manufacturer of Controlled Substances Application: Purisys, LLC [Docket No. DEA–695] Importer of Controlled Substances Application: Epic Pharma, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: VerDate Sep<11>2014 17:02 Aug 10, 2020 Jkt 250001 Purisys, LLC applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Lysergic acid diethylamide and Pentobarbital. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 13, 2020. ADDRESS: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: Epic Pharma, LLC applied to be registered as an importer of the following basic class(es) of a controlled substance: Methadone. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 10, 2020. Such persons may also file a written request for a hearing on the application on or before September 10, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on July 15, 2020, Purisys, SUPPLEMENTARY INFORMATION: PO 00000 Frm 00064 Fmt 4703 7315 I 2270 II The company plans to manufacture the above-listed controlled substances as analytical reference standards and clinical trial material for distribution to its customers. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020–17438 Filed 8–10–20; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–697] Importer of Controlled Substances Application: GE Healthcare Sfmt 4703 GE Healthcare applied to be registered as an importer of the following basic class(es) of a controlled substance: Cocaine. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 10, 2020. Such persons may also file a written request for a hearing on the application on or before September 10, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: Drug Enforcement Administration Drug Enforcement Administration Schedule Drug Enforcement Administration, Justice. ACTION: Notice of application. [FR Doc. 2020–17434 Filed 8–10–20; 8:45 am] DEPARTMENT OF JUSTICE Lysergic acid diethylamide. Pentobarbital ................ Drug code AGENCY: BILLING CODE 4410–09–P BILLING CODE 4410–09–P Controlled substance II [FR Doc. 2020–17432 Filed 8–10–20; 8:45 am] William T. McDermott, Assistant Administrator. LLC, 1550 Olympic Drive, Athens, Georgia 30601–1602, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

[Federal Register Volume 85, Number 155 (Tuesday, August 11, 2020)]
[Notices]
[Page 48563]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17438]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-701]


Bulk Manufacturer of Controlled Substances Application: Purisys, 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Purisys, LLC applied to be registered as a bulk manufacturer 
of the following basic class(es) of controlled substances: Lysergic 
acid diethylamide and Pentobarbital.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before October 13, 
2020.

ADDRESS: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on July 15, 2020, Purisys, LLC, 1550 Olympic Drive, 
Athens, Georgia 30601-1602, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide.............     7315  I
Pentobarbital..........................     2270  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances as analytical reference standards and clinical trial 
material for distribution to its customers. No other activities for 
these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-17438 Filed 8-10-20; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.